Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

2021

Homoharringtonine inhibits the progression of hepatocellular carcinoma by suppressing the PI3K/AKT/GSK3β/Slug signaling pathway
Authors: Hong-Yuan Liu, Tian-Xiu Dong, Zi-Zhuo Li, Tian-Tian Li, Jian Jiang, Ming-Wei Zhu, Ting-Ting An, Yao-Dong Chen, Xiu-Hua Yang
Neoplasma Vol.68, No.5, p.924–937, 2021
doi:10.4149/neo_2021_210113N57
[View Abstract]


PPM1H is an independent prognostic biomarker of non-small cell lung cancer
Authors: Wen-Qi Zhang, Jian-Nan Gao, Xiang-Lei Chen, Xi-Feng Yang
Neoplasma Vol.68, No.5, p.917–923, 2021
doi:10.4149/neo_2021_201117N1238
[View Abstract]


The role of corticotropin-releasing hormone (CRH) family in tumor
Authors: Su-Qin Yi, Jia-Xing An, Cheng-Cheng Liao, Sha Lei, Hai Jin, Bi-Guang Tuo
Neoplasma Vol.68, No.5, p.907–916, 2021
doi:10.4149/neo_2021_210219N226
[View Abstract]


The role of the primary cilium in cancer
Authors: Hong-Tai Cao, Miao-Miao Liu, Quan-Nian Shao, Zuo-Yi Jiao
Neoplasma Vol.68, No.5, p.899–906, 2021
doi:10.4149/neo_2021_210210N204
[View Abstract]


Survival of cancer patients in Fujian, Southeast China: a population-based cancer registry study
Authors: Yan Zhou, Zhi-Sheng Xiang, Jing-Yu Ma, Yong-Tian Lin, Yan-Ping Chen, Hui-Juan Jiang, Lin-Rong Wu, Chuan-Ben Chen
Neoplasma Vol.68, No.4, p.892–898, 2021
doi:10.4149/neo_2021_210203N168
[View Abstract]


Morbidity and mortality after open radical cystectomy and ileal diversion - 10 years experience and a comprehensive assessment in a single tertiary center
Authors: Joana Do Carmo Silva, Marek Babjuk, Štěpán Veselý, Pavel Dušek, Ladislav Jarolím, Antonín Brisuda
Neoplasma Vol.68, No.4, p.882–891, 2021
doi:10.4149/neo_2021_210202N161
[View Abstract]


18F-FDG PET/CT metabolic parameters and HER2 expression in colorectal cancer
Authors: Ziyi Yang, Shuai Liu, Yuyun Sun, Junyan Xu, Jinjin Jiang, Xiaoxi Ma, Yingjian Zhang, Shaoli Song
Neoplasma Vol.68, No.4, p.875–881, 2021
doi:10.4149/neo_2021_200803N807
[View Abstract]


Sonic Hedgehog is a novel prognostic biomarker in patients with oral squamous cell carcinoma
Authors: Piotr Cierpikowski, Anna Lis-Nawara, Julia Bar
Neoplasma Vol.68, No.4, p.867–874, 2021
doi:10.4149/neo_2021_201204N1304
[View Abstract]



Metabolomic profiling of blood plasma of patients with lung cancer and malignant tumors with metastasis in the lungs showed similar features and promising statistical discrimination against controls
Authors: Miroslava Sarlinova, Eva Baranovicova, Michaela Skalicanova, Anton Dzian, Martin Petras, Jan Lehotsky, Dagmar Kalenska, Peter Racay, Tatiana Matakova, Erika Halasova
Neoplasma Vol.68, No.4, p.852–860, 2021
doi:10.4149/neo_2021_210103N3
[View Abstract]


The clinical and prognostic significance of LGR5 in GC: A meta-analysis of IHC assay and bioinformatics analysis
Authors: Fei Guo, Tao Yang, Rende Guo, Yu Wang
Neoplasma Vol.68, No.4, p.842–851, 2021
doi:10.4149/neo_2021_200714N726
[View Abstract]


The combination of PRL-3 inhibitor with sorafenib synergistically promotes AML apoptosis
Authors: Xiaomin Chen, Dade Rong, Wanhua Cai, Xiuzhen Tong, Haihe Wang
Neoplasma Vol.68, No.4, p.832–841, 2021
doi:10.4149/neo_2021_210301N265
[View Abstract]


Heterogeneity and prognosis of programmed cell death-ligand 1 expression in the circulating tumor cells of non-small cell lung cancer
Authors: He-Lin Wang, Jie-Qing Wu, Ying Wang, Jian Yu, Xiao-Na Mao, Zhuo-Ran Li, Hong-Rui Niu, Cai-Ling Jin, Xiao-Jue Wang, Zhuo-Hong Yan, Ling Yi, Bin Yang, Pan-Jian Wei, Hong-Tao Zhang, Shu-Cai Zhang
Neoplasma Vol.68, No.4, p.823–831, 2021
doi:10.4149/neo_2021_210115N67
[View Abstract]


Knockdown of USP9X reverses cisplatin resistance by decreasing β-catenin expression in nasopharyngeal carcinoma cells
Authors: Wen-Xuan Lu, Guo-Sheng Gan, Bo Yang
Neoplasma Vol.68, No.4, p.810–822, 2021
doi:10.4149/neo_2021_201227N1410
[View Abstract]


Depletion of circRNA circ_CDK14 inhibits osteosarcoma progression by regulating the miR-520a-3p/GAB1 axis
Authors: Peng-Fei Wu, Xiao-Ming Tang, Hai-Lang Sun, Hai-Tao Jiang, Jian Ma, Ying-Hui Kong
Neoplasma Vol.68, No.4, p.798–809, 2021
doi:10.4149/neo_2021_201206N1319
[View Abstract]


LncRNA ANRIL promotes multiple myeloma progression and bortezomib resistance by EZH2-mediated epigenetically silencing of PTEN
Authors: Li-Hui Yang, Peng Du, Wei Liu, Li-Kun An, Jian Li, Wen-Yi Zhu, Shuo Yuan, Lei Wang, Lei Zang
Neoplasma Vol.68, No.4, p.788–797, 2021
doi:10.4149/neo_2021_210205N184
[View Abstract]


Circ-sirt1 inhibits growth and invasion of gastric cancer by sponging miR-132-3p/miR-212-3p and upregulating sirt1 expression
Authors: Qing-Ke Li, Yan-Kun Liu, Jing-Wu Li, Yuan-Ting Liu, Yu-Feng Li, Bing-Hui Li
Neoplasma Vol.68, No.4, p.780–787, 2021
doi:10.4149/neo_2021_210218N222
[View Abstract]


The role of angiotensin-(1-7) on acquired platinum resistance-induced angiogenesis in non-small cell lung cancer in vitro and in vivo
Authors: Yan-Lai Geng, Yong-Jie Ding, Lei Ni, Kan-Di Xu, Van-Minh Le, Ri Ji, Yun Feng
Neoplasma Vol.68, No.4, p.770–779, 2021
doi:10.4149/neo_2021_201213N1347
[View Abstract]


CD150 and CD180 are negative regulators of IL-10 expression and secretion in chronic lymphocytic leukemia B cells
Authors: Valeriia Shcherbina, Inna Gordiienko, Larysa Shlapatska, Danilo Gluzman, Svitlana Sidorenko
Neoplasma Vol.68, No.4, p.760–769, 2021
doi:10.4149/neo_2021_210104N8
[View Abstract]


TRIM44 facilitates ovarian cancer proliferation, migration, and invasion by inhibiting FRK
Authors: Xiu-Zhang Yu, Jia-Ling Yuan, Hui Ye, Ke Yi, Ming-Rong Qie, Min-Min Hou
Neoplasma Vol.68, No.4, p.751–759, 2021
doi:10.4149/neo_2021_201128N1285
[View Abstract]





Display #  
Results 21 - 40 of 120

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.